FR520E - Industrial process for the direct extraction of zinc contained in oxidized ores, and more specifically in smithsonite (znco3) and scale (h2zn2sio5) - Google Patents
Industrial process for the direct extraction of zinc contained in oxidized ores, and more specifically in smithsonite (znco3) and scale (h2zn2sio5)Info
- Publication number
- FR520E FR520E FR520DA FR520E FR 520 E FR520 E FR 520E FR 520D A FR520D A FR 520DA FR 520 E FR520 E FR 520E
- Authority
- FR
- France
- Prior art keywords
- h2zn2sio5
- znco3
- smithsonite
- scale
- specifically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR315888T | 1901-11-13 | ||
FR520T | 1902-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR520E true FR520E (en) | 1903-01-26 |
Family
ID=44247281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR520D Expired FR520E (en) | 1901-11-13 | 1902-06-09 | Industrial process for the direct extraction of zinc contained in oxidized ores, and more specifically in smithsonite (znco3) and scale (h2zn2sio5) |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR520E (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014032026A1 (en) | 2012-08-24 | 2014-02-27 | Mitra Ashim K | Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions |
WO2016037157A2 (en) | 2014-09-05 | 2016-03-10 | The Johns Hopkins University | Targeting capn9/capns2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies |
WO2019077123A1 (en) | 2017-10-20 | 2019-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for determining whether a subject has or is at risk of having of an autoimmune myopathy |
WO2020115262A1 (en) | 2018-12-07 | 2020-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of cd26 and cd39 as new phenotypic markers for assessing maturation of foxp3+ t cells and uses thereof for diagnostic purposes |
WO2020148338A1 (en) | 2019-01-15 | 2020-07-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Mutated interleukin-34 (il-34) polypeptides and uses thereof in therapy |
WO2020196873A1 (en) | 2019-03-27 | 2020-10-01 | 学校法人東京医科大学 | Therapeutic agent for wolfram syndrome |
WO2024153636A1 (en) | 2023-01-17 | 2024-07-25 | Institut National de la Santé et de la Recherche Médicale | Vasorin as a biomarker and biotarget in nephrology |
-
1902
- 1902-06-09 FR FR520D patent/FR520E/en not_active Expired
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014032026A1 (en) | 2012-08-24 | 2014-02-27 | Mitra Ashim K | Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions |
EP4218729A1 (en) | 2012-08-24 | 2023-08-02 | Sun Pharmaceutical Industries Limited | Topical formulations and uses thereof |
WO2016037157A2 (en) | 2014-09-05 | 2016-03-10 | The Johns Hopkins University | Targeting capn9/capns2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies |
WO2019077123A1 (en) | 2017-10-20 | 2019-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for determining whether a subject has or is at risk of having of an autoimmune myopathy |
WO2020115262A1 (en) | 2018-12-07 | 2020-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of cd26 and cd39 as new phenotypic markers for assessing maturation of foxp3+ t cells and uses thereof for diagnostic purposes |
WO2020148338A1 (en) | 2019-01-15 | 2020-07-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Mutated interleukin-34 (il-34) polypeptides and uses thereof in therapy |
WO2020196873A1 (en) | 2019-03-27 | 2020-10-01 | 学校法人東京医科大学 | Therapeutic agent for wolfram syndrome |
WO2024153636A1 (en) | 2023-01-17 | 2024-07-25 | Institut National de la Santé et de la Recherche Médicale | Vasorin as a biomarker and biotarget in nephrology |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR520E (en) | Industrial process for the direct extraction of zinc contained in oxidized ores, and more specifically in smithsonite (znco3) and scale (h2zn2sio5) | |
SE8008053L (en) | PROCEDURE FOR Separating and Extracting Nickel and Copper from Complex Materials | |
SE8401238L (en) | PROCEDURE FOR EXPLOITING THE METAL WORLD OF IRON-INHALING MATERIAL | |
FR2408660A1 (en) | TITANIUM RECOVERY PROCESS | |
FR2424962A1 (en) | PROCESS FOR RECOVERING NON-FERROUS METALS BY THERMAL TREATMENT OF SOLUTION CONTAINING SULPHATES OF THESE METALS AND IRON | |
ATE15502T1 (en) | PROCESSES FOR RECOVERING THE METAL CONTENT FROM COMPLEX SULFIDIC RAW MATERIALS. | |
CA55875A (en) | Process for the treatment of auriferous and argentiferous ores | |
GB190415577A (en) | Improvements in the Recovery of Metals from Ores and other Material | |
CA75068A (en) | Process of recovering and separating metals from their ores and concentrates thereof | |
GB189900350A (en) | A New or Improved Method of and Means for the Concentration or Separation and Amalgamation of Crushed Ores or Mineral Slimes. | |
GB190124026A (en) | Improvements in the Method of and Apparatus for the Recovery of Precious Metals from Ores and Slimes. | |
AU357905B (en) | Improvements in and relating' to method of and apparatus for placer mining | |
GB190105265A (en) | Improvements in and relating to the Recovery of Precious Metals by Electrolysis. | |
FR410901A (en) | Process for the separation of metals soluble in alkalis from wastes and alloys containing such metals | |
FR370910A (en) | Process for the reduction and smelting of ores and the like | |
FR5106E (en) | Method and device for extracting metals from ores and other metalliferous materials, by dissolution and electrolysis | |
FR391032A (en) | Process for the extraction of precious and other metals combined and coated in their ores | |
FR317882A (en) | New process and solution for the separation of metals from sulphurous ores | |
GB190424585A (en) | Improvements in or relating to the Treatment of Copper Ore. | |
FR460439A (en) | Chemical process for extracting gold from auriferous mispickel ores and other arsenical ores | |
GB190100331A (en) | Improvements in or relating to Obtaining Antimony and Separating Gold from Antimony Ores. | |
GB190106519A (en) | An Improvement in Separating Mineral Substances by the Selective Action of Oil. | |
FR356825A (en) | Method and device for extracting metals from ores and other metalliferous materials, by dissolution and electrolysis | |
AU297705B (en) | Improvements in apparatus for treating slimes produced in the reduction of auriferous ores, for the recovery of the precious metal | |
FR430591A (en) | Process for the separation of fixed metals from gangue in the processing of complex ores containing fixed and volatile metals |